about
Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery.Surface-engineered graphene-based nanomaterials for drug delivery.Disulfide-Bridged Cleavable PEGylation of Poly-L-Lysine for SiRNA Delivery.Suppression of VEGF by reversible-PEGylated histidylated polylysine in cancer therapy.Reduction-cleavable polymeric vesicles with efficient glutathione-mediated drug release behavior for reversing drug resistance.Effective gene delivery using stimulus-responsive catiomer designed with redox-sensitive disulfide and acid-labile imine linkers.Cleavable PEGylation and hydrophobic histidylation of polylysine for siRNA delivery and tumor gene therapy.A facile one-pot construction of supramolecular polymer micelles from alpha-cyclodextrin and poly(epsilon-caprolactone).A versatile multicomponent assembly via β-cyclodextrin host-guest chemistry on graphene for biomedical applications.Delivery of MicroRNA-1 Inhibitor by Dendrimer-based Nanovector: an Early Targeting Therapy for Myocardial Infarction in Mice.Degradable and tunable supramolecular polymer micelles for drug delivery.Self-Templated, Green-Synthetic, Size-Controlled Protein Nanoassembly as a Robust Nanoplatform for Biomedical Application.Engineering of a Pluronic F127 functionalized magnetite/graphene nanohybrid for chemophototherapy.Fever-Inspired Immunotherapy Based on Photothermal CpG Nanotherapeutics: The Critical Role of Mild Heat in Regulating Tumor Microenvironment."Minimalist" Nanovaccine Constituted from Near Whole Antigen for Cancer ImmunotherapySupramolecular polymer micelles self-assembled from α-cyclodextrin and PLLA-PCL based copolymersMesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled releaseA nano-immunotraining strategy to enhance the tumor targeting of neutrophils via in vivo pathogen-mimicking stimulationRemodeling of Cellular Surfaces via Fast Disulfide-Thiol Exchange To Regulate Cell BehaviorsSelf-Albumin Camouflage of Carrier Protein Prevents Nontarget Antibody Production for Enhanced LDL-C ImmunotherapyCa2+-Mediated Surface Polydopamine Engineering to Program Dendritic Cell Maturation
P50
Q31035899-05ED7BB0-1E68-48EF-8ACE-45B9E512D24AQ38493530-E18ED2BB-588B-4814-AEBF-FB7B805E89DBQ38827555-B41A03C6-4CDC-4345-BA1C-02B6FB096DB5Q38997478-EDA35D17-926E-45F7-969B-119A99DCBACAQ39089391-59D0DF66-50C7-41E5-A83A-226D33AF4B42Q39637225-31331F3B-D579-45A0-A45A-840330FCE816Q45865658-05936E0D-D3A2-4DE7-97D9-460E2F15351FQ46529314-1AAA30E8-150B-4EB1-9A08-A9B7B4694788Q46839203-BB0BCFB9-23D5-4119-B781-FD5288B00179Q47226856-8C5636F5-75D1-454B-9AE9-9DAF540750CFQ51423979-16EDF96F-5004-4BA8-9A25-329FBF5A441DQ51744011-31DC6C32-8025-4768-96BA-20EFC4649188Q53637899-A1B85A05-E666-4F2F-8AF5-98EF9EACD6BDQ55358544-E0311AA6-0EA8-478A-AB6B-FEF9B5E73D1DQ57174823-C2674F09-F464-4D01-AC5F-C993AB5DFED2Q83128250-2119AA9C-7281-4CA1-A7AA-D0F54404FFF2Q84246539-342BCAAA-16B0-4BD8-B1BE-2518950C5F0AQ90644522-889E1AEB-92F8-41CB-9BB1-724E63C1AC2DQ91483599-B1BE3EA2-8E63-40A4-A4D4-39C1BAD07412Q91785928-6993CDA1-E813-4881-A289-E68906FB1719Q92350262-044C0E2A-3E78-45CA-986A-313554978031
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yongyong Li
@ast
Yongyong Li
@en
Yongyong Li
@es
Yongyong Li
@nl
Yongyong Li
@sl
type
label
Yongyong Li
@ast
Yongyong Li
@en
Yongyong Li
@es
Yongyong Li
@nl
Yongyong Li
@sl
prefLabel
Yongyong Li
@ast
Yongyong Li
@en
Yongyong Li
@es
Yongyong Li
@nl
Yongyong Li
@sl
P106
P31
P496
0000-0002-6688-5978